Author:
Jädersten Martin,Hellström-Lindberg Eva
Reference46 articles.
1. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol.,2009
2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow,2008
3. Distinct haematological disorder with deletion of long arm of no. 5 chromosome;Van den Berghe;Nature,1974
4. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31;Giagounidis;Leukemia,2004
5. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome;Boultwood;Blood,2002
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献